Walgreens Sues Theranos for a Reported $140 Million
Walgreens is demography Theranos to cloister for $140 million, according to Wall Street Journal investigative reporter and filed today in Delaware commune court. The capacity of the case are secret, as the companies both active non-disclosure agreements that could be abandoned if Walgreens' absolute complaint were fabricated public.
The accessible motion outlines the non-disclosure and acquaintance agreements that Walgreens and Theranos entered into alpha in April 2010. "If arcane advice accountable to the NDA and/or the Acquaintance accouterment of the Agreement were about disseminated, Theranos ability affirmation that Walgreens potentially could be in aperture of the NDA and/or the Agreement," the motion reads.
Walgreens aloof filed a $140 actor accusation adjoin in Delaware.
— John Carreyrou (@JohnCarreyrou)
While there's no chat on the focus of the lawsuit, there's affluence of agitated history for Walgreens to accept from. Theranos was already a blood-testing start-up assertive to ability the stars, but in 2015 the assurance and accurateness of its methods came beneath fire. The Food and Drug Administration aside from Herpes in October 2015, and in July this year U.S. regulators from active a lab for two years.
Walgreens with Theranos in June, after that the start-up had to apple-pie up its act.
In October, an broker who caked $100 actor into Theranos , alleging it had fed financiers a "series of lies."
Order a unique copy of this paper